Anticancer Potential of L-Histidine-Capped Silver Nanoparticles Against Human Cervical Cancer Cells (SiHA)
Overview
Authors
Affiliations
This study reports the synthesis of silver nanoparticles using amino acid L-histidine as a reducing and capping agent as an eco-friendly approach. Fabricated L-histidine-capped silver nanoparticles (L-HAgNPs) were characterized by spectroscopic and microscopic studies. Spherical shaped L-HAgNPs were synthesized with a particle size of 47.43 ± 19.83 nm and zeta potential of -20.5 ± 0.95 mV. Results of the anticancer potential of L-HAgNPs showed antiproliferative effect against SiHa cells in a dose-dependent manner with an IC value of 18.25 ± 0.36 µg/mL. Fluorescent microscopic analysis revealed L-HAgNPs induced reactive oxygen species (ROS) mediated mitochondrial dysfunction, leading to activation of apoptotic pathway and DNA damage eventually causing cell death. To conclude, L-HAgNPs can act as promising candidates for cervical cancer therapy.
Nanoparticles in gynecologic cancers: a bibliometric and visualization analysis.
Zhou Y, Chen L, Wang T Front Oncol. 2025; 14():1465987.
PMID: 39845315 PMC: 11750695. DOI: 10.3389/fonc.2024.1465987.
Xie W, Xu Z Front Immunol. 2024; 15:1461894.
PMID: 39346915 PMC: 11427397. DOI: 10.3389/fimmu.2024.1461894.
Wong Y, Lee S Curr Drug Discov Technol. 2024; 21(6):e220224227304.
PMID: 38409702 DOI: 10.2174/0115701638290855240207114727.
Activities against Lung Cancer of Biosynthesized Silver Nanoparticles: A Review.
Mejia-Mendez J, Lopez-Mena E, Sanchez-Arreola E Biomedicines. 2023; 11(2).
PMID: 36830926 PMC: 9953519. DOI: 10.3390/biomedicines11020389.
Siva D, Abinaya S, Rajesh D, Archunan G, Padmanabhan P, Gulyas B Nanomaterials (Basel). 2022; 12(3).
PMID: 35159847 PMC: 8838624. DOI: 10.3390/nano12030502.